{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:42:49Z","timestamp":1761892969884},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2001,8,28]]},"DOI":"10.1212\/wnl.57.4.691","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:55:37Z","timestamp":1336917337000},"page":"691-697","source":"Crossref","is-referenced-by-count":24,"title":["Ischemic stroke outcome"],"prefix":"10.1212","volume":"57","author":[{"given":"H.","family":"Hassaballa","sequence":"first","affiliation":[{"name":"From the Departments of Internal Medicine (Dr. Hassaballa), Neurological Sciences (Dr. Gorelick), Rush Presbyterian St. Luke\u2019s Medical Center, Chicago, IL; Department of Internal Medicine (Dr. West), Mayo Graduate School of Medicine, Rochester, MN; College of Public Health (M. Hansen), University of Iowa, Iowa City; and Department of Neurology (Dr. Adams), Division of Cerebrovascular Diseases, University of Iowa College of Medicine, Iowa City."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. B.","family":"Gorelick","sequence":"additional","affiliation":[{"name":"From the Departments of Internal Medicine (Dr. Hassaballa), Neurological Sciences (Dr. Gorelick), Rush Presbyterian St. Luke\u2019s Medical Center, Chicago, IL; Department of Internal Medicine (Dr. West), Mayo Graduate School of Medicine, Rochester, MN; College of Public Health (M. Hansen), University of Iowa, Iowa City; and Department of Neurology (Dr. Adams), Division of Cerebrovascular Diseases, University of Iowa College of Medicine, Iowa City."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. P.","family":"West","sequence":"additional","affiliation":[{"name":"From the Departments of Internal Medicine (Dr. Hassaballa), Neurological Sciences (Dr. Gorelick), Rush Presbyterian St. Luke\u2019s Medical Center, Chicago, IL; Department of Internal Medicine (Dr. West), Mayo Graduate School of Medicine, Rochester, MN; College of Public Health (M. Hansen), University of Iowa, Iowa City; and Department of Neurology (Dr. Adams), Division of Cerebrovascular Diseases, University of Iowa College of Medicine, Iowa City."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. D.","family":"Hansen","sequence":"additional","affiliation":[{"name":"From the Departments of Internal Medicine (Dr. Hassaballa), Neurological Sciences (Dr. Gorelick), Rush Presbyterian St. Luke\u2019s Medical Center, Chicago, IL; Department of Internal Medicine (Dr. West), Mayo Graduate School of Medicine, Rochester, MN; College of Public Health (M. Hansen), University of Iowa, Iowa City; and Department of Neurology (Dr. Adams), Division of Cerebrovascular Diseases, University of Iowa College of Medicine, Iowa City."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"H. P.","family":"Adams","sequence":"additional","affiliation":[{"name":"From the Departments of Internal Medicine (Dr. Hassaballa), Neurological Sciences (Dr. Gorelick), Rush Presbyterian St. Luke\u2019s Medical Center, Chicago, IL; Department of Internal Medicine (Dr. West), Mayo Graduate School of Medicine, Rochester, MN; College of Public Health (M. Hansen), University of Iowa, Iowa City; and Department of Neurology (Dr. Adams), Division of Cerebrovascular Diseases, University of Iowa College of Medicine, Iowa City."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.29.12.2656"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.15.2.249"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.39.9.1165"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.22.12.1491"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.29.2.415"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009445"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.1_Part_1.27"},{"key":"e_1_3_1_9_2","first-page":"1215","volume":"1","year":"1989","unstructured":"Gent M, Blakeley JA, Easton JD, et al. The Canadian-American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet . 1989; 1: 1215\u20131220.","journal-title":"Lancet"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199108153250701"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512143332401"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03520420037035"},{"key":"e_1_3_1_13_2","first-page":"630","volume":"88","year":"1996","unstructured":"Harris Y, Gorelick PB, Samuels P, Beupong I. Why African Americans may not be participating in clinical trials. J Nat Med Assoc . 1996; 88: 630\u2013634.","journal-title":"J Nat Med Assoc"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1052-3057(98)80127-4"},{"key":"e_1_3_1_15_2","doi-asserted-by":"crossref","unstructured":"The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators: low molecular weight heparinoid ORG 10172 (Danaparoid) and outcome after acute ischemic stroke: a randomized controlled trial. JAMA 1998;279:1265\u20131272.","DOI":"10.1001\/jama.279.16.1265"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.27.10.1817"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(75)92830-5"},{"key":"e_1_3_1_18_2","first-page":"61","volume":"14","year":"1965","unstructured":"Mahoney FI, Barthel DW. Function evaluation: the Barthel Index. Md State Med J . 1965; 14: 61\u201365.","journal-title":"Md State Med J"},{"key":"e_1_3_1_19_2","first-page":"126","volume":"3","year":"1999","unstructured":"Adams HP, Davis PH, Leira EC, et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology . 1999; 3: 126\u2013131.","journal-title":"Neurology"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000109798"},{"key":"e_1_3_1_21_2","first-page":"28","volume":"96","year":"1993","unstructured":"Gorelick PB, Harris Y. Stroke: an excess burden on African Americans. Chicago Med . 1993; 96: 28\u201330.","journal-title":"Chicago Med"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000109683"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.30.1.34"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-9842(00)00067-2"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.29.12.2455"},{"key":"e_1_3_1_26_2","doi-asserted-by":"crossref","unstructured":"Gillum   RF Thomas   J Curry   CL.   Atrial fibrillation heart disease and ischemic stroke in blacks. In:  Gillum  RF Gorelick  PB Cooper  ES eds.  Stroke in blacks.   Basel:   Karger 1999:  129\u2013141.","DOI":"10.1159\/000062902"},{"key":"e_1_3_1_27_2","unstructured":"Abel GA Sacco RL Lin I-F et al. Race-ethnic variability in etiologic fraction for stroke risk factors: the Northern Manhattan Stroke study. In: Program and abstracts of the 23rd International Joint Conference on Stroke and Cerebral Circulation; February 5\u20137 1998; Orlando FL."},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.22.2.169"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.24.4.532"},{"key":"e_1_3_1_30_2","first-page":"249","volume":"13","year":"1991","unstructured":"de Falco FA, Mastroroberto G, Mazzei G, Montariello A, Zaccaria F, Sepe Visconti O. Atrial fibrillation and infarct area extent in ischemic stroke. A clinical and neuroradiological study in 104 patients. Acta Neurol . 1991; 13: 249\u2013254.","journal-title":"Acta Neurol"},{"key":"e_1_3_1_31_2","doi-asserted-by":"crossref","unstructured":"Lin HJ Wolf PA Kelly\u2013Hayes M et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke 1996;27:1760\u20131764.","DOI":"10.1161\/01.STR.27.10.1760"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.305.6867.1460"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199702133360706"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1994.00420070077009"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1993.00410240093011"},{"key":"e_1_3_1_36_2","doi-asserted-by":"crossref","unstructured":"Giles   WH Croft   JB Casper   ML Miller   JK.   Stroke incidence comorbid conditions health care utilization and poststroke mortality in black and white Medicare beneficiaries: national patterns and trends. In:  Gillum  RF Gorelick  PB Cooper  ES eds.  Stroke in blacks.   Basel:   Karger 1999:  106\u2013117.","DOI":"10.1159\/000062900"},{"key":"e_1_3_1_37_2","doi-asserted-by":"crossref","unstructured":"Gillum   RF.   Epidemiology of stroke in blacks. In:  Gillum  RF Gorelick  PB Cooper  ES eds.  Stroke in blacks.   Basel:   Karger 1999:  83\u201393.","DOI":"10.1159\/000062914"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.4.891"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-9993(98)90271-4"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.1.208"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.12.1112"},{"key":"e_1_3_1_42_2","doi-asserted-by":"crossref","unstructured":"Caplan LR. Cerebral ischemia and infarction in blacks. In: Gillum RF Gorelick PB Cooper ES eds. Stroke in blacks. Basel Karger 1999:7\u201318.","DOI":"10.1159\/000062916"},{"key":"e_1_3_1_43_2","doi-asserted-by":"crossref","unstructured":"Ford Lynch   GF Washington   J Gorelick   PB.   Lacunar stroke in black patients. In:  Gillum  RF Gorelick  PB Cooper  ES eds.  Stroke in blacks.   Basel:   Karger 1999:  19\u201328.","DOI":"10.1159\/000062912"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.31.3.563"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.22.12.1497"},{"key":"e_1_3_1_46_2","doi-asserted-by":"crossref","unstructured":"Goldstein   LB Hoenig   H.   Stroke rehabilitation in African-American patients. In:  Gillum  RF Gorelick  PB Cooper  ES eds.  Stroke in blacks.   Basel:   Karger 1999:  198\u2013209.","DOI":"10.1159\/000062908"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.28.1.19"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1995.00540270038017"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.26.3.392"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.57.4.691","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T12:14:54Z","timestamp":1711541694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.57.4.691"}},"subtitle":["Racial differences in the trial of danaparoid in acute stroke (TOAST)"],"short-title":[],"issued":{"date-parts":[[2001,8,28]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,8,28]]}},"alternative-id":["10.1212\/WNL.57.4.691"],"URL":"https:\/\/doi.org\/10.1212\/wnl.57.4.691","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8,28]]}}}